C07D 265/28
1,4-oxazines
Official title: 1,4-Oxazines; Hydrogenated 1,4-oxazines
C07D265/28 (1,4-oxazines) appears on 2,117 US grants and 2,010 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,117
- Published applications
- 2,010
- Assignees
- 1,073
- Inventors
- 6,594
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 20 | 0 |
| 1978 | 37 | 0 |
| 1979 | 18 | 0 |
| 1980 | 23 | 0 |
| 1981 | 30 | 0 |
| 1982 | 15 | 0 |
| 1983 | 20 | 0 |
| 1984 | 16 | 0 |
| 1985 | 15 | 0 |
| 1986 | 31 | 0 |
| 1987 | 27 | 0 |
| 1988 | 19 | 0 |
| 1989 | 30 | 0 |
| 1990 | 32 | 0 |
| 1991 | 20 | 0 |
| 1992 | 26 | 0 |
| 1993 | 35 | 0 |
| 1994 | 26 | 0 |
| 1995 | 40 | 0 |
| 1996 | 24 | 0 |
| 1997 | 33 | 0 |
| 1998 | 41 | 0 |
| 1999 | 31 | 0 |
| 2000 | 31 | 0 |
| 2001 | 42 | 9 |
| 2002 | 41 | 50 |
| 2003 | 54 | 41 |
| 2004 | 20 | 63 |
| 2005 | 26 | 84 |
| 2006 | 37 | 86 |
| 2007 | 33 | 62 |
| 2008 | 51 | 50 |
| 2009 | 53 | 84 |
| 2010 | 57 | 116 |
| 2011 | 46 | 85 |
| 2012 | 63 | 72 |
| 2013 | 61 | 86 |
| 2014 | 72 | 99 |
| 2015 | 89 | 102 |
| 2016 | 80 | 109 |
| 2017 | 99 | 97 |
| 2018 | 73 | 95 |
| 2019 | 82 | 83 |
| 2020 | 71 | 118 |
| 2021 | 71 | 76 |
| 2022 | 80 | 64 |
| 2023 | 49 | 95 |
| 2024 | 39 | 79 |
| 2025 | 32 | 70 |
| 2026 | 37 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Derivatives of substituted morpholines and uses thereof29 Sep 2026US 12,747,218 B2Supernus Pharmaceuticals, Inc.
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
- Herbicidal composition and method for controlling weeds3 Sep 2026US 2026/0256143 A1Enko Chem, Inc.
- Ferroptosis inhibitors and uses thereof27 Aug 2026US 2026/0248800 A1
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Methadone Active Agents and Methods of Use Thereof6 Aug 2026US 2026/0226000 A1Ensysce Biosciences Inc.
Most cited
By later US patents
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Amide complexes151US 5,693,310 ASchering Corporation · 1997
- Bupropion metabolites and methods of use151US 6,342,496 B12002